Although there have been discussions about using different Covid-19 vaccines in combination, World Health Organization (WHO) chief scientist Soumya Swaminathan warned against it, calling it a “dangerous trend.”

PRECISIONeffect announced the promotion of two long-term employees who have made significant and strategic contributions to client work from the healthcare advertising agency’s London office: Simon Wilson and Elizabeth Spencer.

The Euro 2020 soccer tournament was blamed for a surge in coronavirus cases as fans have flocked to stadiums, bars and spectator zones across Europe to watch the action while the pandemic still raged.

With an $850 million investment from parent company Fujifilm Corporation, Fujifilm Diosynth Biotechnologies is expanding the company’s manufacturing capabilities to support an increased capacity for biologics and gene therapies. 

A third shot of the Oxford-AstraZeneca Covid-19 vaccine produces a strong immune response, researchers said on June 28, adding there was not yet evidence that such shots were needed, especially given shortages in some countries.

AstraZeneca said a late-stage trial failed to provide evidence that the company’s Covid-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines.

Novavax Inc. said vaccine efficacy appeared to be preserved in those receiving an approved influenza vaccine along with the company’s Covid-19 vaccine candidate compared to those receiving its Covid-19 vaccine alone.

UK researchers led by a group at Newcastle University identified a gene, HLA-DRB1*04:01, which was three times more common in asymptomatic Covid-19 patients than in people with symptomatic disease. The research was published in the journal HLA.

AstraZeneca’s $39 billion acquisition of Alexion is being investigated by the UK’s Competition and Markets Authority (CMA) to determine if the deal is anti-competitive.

A double dose of Covid-19 vaccines is almost as effective against the fast-spreading variant of the coronavirus first identified in India as it is against Britain’s dominant strain, English health officials said on May 22.